Enhanced interaction between Hsp90 and raptor regulates mTOR signaling upon T cell activation
- 7 July 2009
- journal article
- research article
- Published by Elsevier in Molecular Immunology
- Vol. 46 (13), 2694-2698
- https://doi.org/10.1016/j.molimm.2009.05.185
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R01CA098109, R01CA14227)
This publication has 11 references indexed in Scilit:
- Hsp90: A Novel Target for the Disruption of Multiple Signaling CascadesCurrent Cancer Drug Targets, 2007
- A Role for Mammalian Target of Rapamycin in Regulating T Cell Activation versus AnergyThe Journal of Immunology, 2007
- Ablation in Mice of the mTORC Components raptor, rictor, or mLST8 Reveals that mTORC2 Is Required for Signaling to Akt-FOXO and PKCα, but Not S6K1Developmental Cell, 2006
- Dissecting the mechanism of T-cell anergy with immunophilin ligands.2006
- mTOR and cancer: insights into a complex relationshipNature Reviews Cancer, 2006
- Prolonged TCR/CD28 Engagement Drives IL-2-Independent T Cell Clonal Expansion through Signaling Mediated by the Mammalian Target of RapamycinThe Journal of Immunology, 2006
- Suppression of the mTOR-Raptor Signaling Pathway by the Inhibitor of Heat Shock Protein 90 GeldanamycinThe Journal of Biochemistry, 2006
- Targeting the mammalian target of rapamycin (mTOR): a new approach to treating cancerBritish Journal of Cancer, 2004
- T Cell AnergyAnnual Review of Immunology, 2003
- Inhibition of Cell Cycle Progression by Rapamycin Induces T Cell Clonal Anergy Even in the Presence of CostimulationThe Journal of Immunology, 1999